The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials

Abstract The neoadjuvant and adjuvant anti-PD-1/PD-L1 treatment has been increasingly noticed. To summarize the global landscape of these clinical trials will provide essential data for all the stakeholders of drug development. Based on the Trialtrove database, a total of 668 clinical trials initiat...

Full description

Bibliographic Details
Main Authors: Dawei Wu, Huiyao Huang, Minghui Zhang, Ziwei Li, Shuhang Wang, Yue Yu, Yuan Fang, Ning Jiang, Huilei Miao, Peiwen Ma, Yu Tang, Ning Li
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Journal of Hematology & Oncology
Subjects:
Neoadjuvant
Adjuvant
Anti-PD-1/PD-L1 treatment
Clinical trial
Online Access:https://doi.org/10.1186/s13045-022-01227-1

Internet

https://doi.org/10.1186/s13045-022-01227-1

Similar Items